Rimonabant: A CB1 Receptor Antagonist as a Direct Interactional Partner for Μ- And Δ-Opioid Receptor

doi 10.14232/phd.2233
Full Text
Abstract

Available in full text

Date

Unknown

Authors
Publisher

University of Szeged

Related search

Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy Μ Opioid Receptor (MOR) Agonist/Δ Opioid Receptor (DOR) Antagonist Ligands

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2013English

Μ-Opioid Receptor Forms a Functional Heterodimer With Cannabinoid CB1 Receptor: Electrophysiological and FRET Assay Analysis

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2008English

Μ Opioid and CB1 Cannabinoid Receptor Interactions: Reciprocal Inhibition of Receptor Signaling and Neuritogenesis

British Journal of Pharmacology
Pharmacology
2009English

A Μ-Opioid Receptor-Filter Assay

Biochemical Pharmacology
BiochemistryPharmacology
1988English

Characterization of Methadone as a Β-Arrestin-Biased Μ-Opioid Receptor Agonist

Molecular Pain
Molecular MedicineAnesthesiologyPain MedicineCellularMolecular Neuroscience
2016English

Orally Administered H-DMT-Tic-Lys-Nh-Ch2-Ph (MZ-2), a Potent Μ-/Δ-Opioid Receptor Antagonist, Regulates Obese-Related Factors in Mice

European Journal of Pharmacology
Pharmacology
2009English

The Subtleties of Μ-Opioid Receptor Phosphorylation

British Journal of Pharmacology
Pharmacology
2011English

Μ Opioid Receptor Phosphorylation, Desensitization, and Ligand Efficacy

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1997English

Prejunctional and Peripheral Effects of the Cannabinoid CB1 Receptor Inverse Agonist Rimonabant (SR 141716)

Naunyn-Schmiedeberg's Archives of Pharmacology
MedicinePharmacology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy